The National Institute on Drug Abuse is soliciting proposals from qualified organizations having the capability to

(1) grow, harvest, analyze, store and distribute GMP grade cannabis (marijuana) on large and small scales;
(2) extract cannabis to obtain purified phytocannabinoids including delta-9-tetrahydrocannabinol (delta-9-THC), analyze, and store;
(3) prepare marijuana cigarettes and related products; and
(4) distribute marijuana, marijuana cigarettes and cannabinoids, and other related products for research and other Government programs upon NIDA authorization.

Offeror must possess suitable and secure DEA approved outdoor and indoor growing facilities, research laboratory with appropriate analytical instruments, and experienced personnel to conduct the project tasks. Appropriate DEA approved secure facility for manufacturing of marijuana cigarettes, and their storage, and DEA Schedule I registration for marijuana and THC are essential.

NIDA anticipates a 1-year with four 1 year options cost reimbursement type contract will be awarded. Additional quantity options for manufacturing cigarettes may also be required.

In order to handle substances under the Controlled Substances Act of 1970, it is mandatory that offerors possess a DEA Research Registration for Schedules II to V and demonstrate the capability to obtain a DEA registration for Schedule I controlled substances. All studies must be carried out under pertinent FDA regulations, such as current Good Clinical Practice (cGCP) and current Good Laboratory Practice (cGLP) regulations.

Paging Dr. Lyle Craker, please pick up the green courtesy phone!  I’ve got to believe that this is just a mere formality preceding the rewarding of this contract once again to Dr. Mahmoud ElSohly and the federal pot farm at the University of Mississippi.  But I guess it wouldn’t hurt for a few prestigious researchers like Dr. Craker to apply.

Related posts

• Marijuana potency surpasses 10 percent, U.S. says (9)
• Growing Marijuana With Government Money (1)
• What reasonable reporting on the testicular cancer study looks like (1)

Oregon Senate Bill 728 passed the Senate by a vote of 26-2, the House passed it 58-1, and the Senate concurred on amendments 26-3.  It now awaits Gov. Kulongoski’s signature.  The measure adds new sections to Oregon’s law on controlled substances:

SECTION 2. The State Board of Pharmacy shall classify marijuana as a controlled substance in Schedule II, III, IV or V.

SECTION 4. (1) The State Board of Pharmacy shall classify marijuana in accordance with section 2 of this 2009 Act no later than 180 days after the effective date of this 2009 Act.

Oregon’s drug scheduling definitions mirror those of the federal government, so what this means is that Oregon no longer considers marijuana to be a drug with “a high potential for abuse” that “has no currently accepted medical use in treatment in the United States” and no “accepted safety for use of the drug or other substance under medical supervision.”

Instead, no matter where Oregon places marijuana on the scale from II to V sometime in early 2010, the state recognizes that marijuana “has a currently accepted medical use in treatment in the United States.”

This doesn’t mean that Oregon doctors will begin prescribing marijuana; the federal Schedule I classification will still be in effect and doctor’s ability to prescribe narcotics usually requires a federal license.  However, it does mean that the entire sentencing structure for “crimes” involving marijuana changes in Oregon.  It also provides another point for those who challenge the federal assertion that marijuana has no recognized medical use in the United States – one of your states has written it into the law!

Oregon activist Laird Funk notes:

While the bill’s author, Sen Prozanski, opined at hearings that mj should probably end up in schedule 3, the Board will make its decision based on the result of evidence presented at a hearing or hearings. There is significant evidence that mj should be lower than schedule 3 and part of that evidence is contained in SB 728 itself, where it discusses schedule 4 substances which cause death. If schedule 4 substances can cause death, and cannabis has never caused death, (a fact I pointed out in the House hearings on 728) then logically it should be in schedule 5, given the mandate of the bill to place it in 2 thru 5.

I am asking all folks involved in cannabis reform efforts nationwide to take advantage of this opportunity and help Oregonians prepare the needed convincing evidence to place mj as low as possible. To that end, I am asking all who read this, who are on other lists to please re-post this to those lists so that all might be best prepared to make this opportunity to reschedule work best for us all.

I will be contacting the Board of Pharmacy soon to ascertain their thoughts on the scheduling of the hearings and other parts of the process and will keep all informed as to the results of that contact. With a collaborative approach, we may be in a position to guide the Board to the right conclusion.

Related posts

• Los Angeles Times: Reefer-tax madness (2)
• Two San Antonio women die from Fentanyl patches (2)
• This is your chance to tell the White House… again… (2)

(WOAI.com) SAN ANTONIO — Controversy is brewing over a patch used for pain relief. At least two people in San Antonio have died after using the Fentanyl patch, and their families are blaming what they say is a defect.

Like most medicinal patches, Fentanyl is used by peeling off a sticky side and placing it against the skin of a patient. The patch is left on the skin for up to 72 hours and is supposed to provide the exact amount of medication needed.

However, the families of two San Antonio women who died say the patch they were prescribed to relieve their pain ended up killing them.

According to lawsuits filed by family members, both women suffered chronic pain. So, their doctors suggested Fentanyl patches.

Fentanyl is stronger than morphine. When it is applied to the skin, it then delivers a certain amount of Fentanyl into the patient.

While wearing the patches, Donna Singleton and Ellen Burks died. Their families say both suffered an overdose of Fentanyl because the patches were defective.

Similar patches have been recalled before because a cut along the side of the patch allowed too much Fentanyl to leak and cause a possible overdose.

Wait a minute, didn’t the Food & Drug Administration approve the use of these Fentanyl patches?  Why, doesn’t that mean it’s safe?  We know for sure that the FDA wouldn’t let people stick a patch on their body loaded with a Schedule II drug if it weren’t safe, even if this Fentanyl is just one isomer short of being Schedule I “China White” heroin.

We know this because they protect us from that evil Schedule I medical marijuana that never killed anybody in 5,000 years.

Related posts

• Stash for Tue, Jun 30, 2009 (0)
• Washington Post opinion article on medical marijuana is an insult to our intelligence (2)
• This is your chance to tell the White House… again… (2)

"Rethink and Decriminalize..." Doesn't everybody want to be NORML? (credit K.B.)

This is your chance to tell the White House what you think about the Government’s long-standing refusal to acknowledge the medical benefits of cannabis and its obstruction of medical cannabis research.

Visit http://www.safeaccessnow.org/ScientificIntegrity and choose one of the following three options to comment on:

1. The U.S Department of Health and Human Services must correct statements disseminated on federal websites and in the Federal Register that falsely declare that cannabis “has no currently accepted medical use in treatment in the United States.”
2. The U.S. Drug Enforcement Administration must accept the Administrative Law Judge Bittner’s February 2007 Opinion and Recommended Ruling in the matter of Lyle E. Craker, Ph.D., Docket No. 05-16, to grant a competitive bulk-manufactures license to establish a privately-funded facility to cultivate cannabis exclusively for clinical research.
3. The U.S. Department of Justice must remove cannabis from the list of Schedule I controlled substances in light of a growing body of research, including four double-blind placebo controlled clinical trials, which supports the therapeutic use of cannabis and in accordance with DEA’s own 1988 Administrative Law ruling in which Judge Young opined that “the provisions of the CSA permit and require the transfer of cannabis from schedule I to schedule II.”

Tell Obama to Stand for Scientific Integrity in Medical Cannabis, Too!

“President Obama has made it clear that his administration will hold science over political ideology and value the input of people like you.

Last month, the President signed a Memorandum on Scientific Integrity affirming that policy decisions that are made are done so with facts and data, not political agendas. And now the Office of Technology and Science Policy (OTSP), the agency responsible for overseeing the scientific integrity pledge, created a way for you to provide feedback.

There is a scientific consensus that cannabis can control symptoms of serious and chronic illness. In the past decade alone, clinical research has demonstrated that cannabis and its constituents can safely and effectively treat nausea and vomiting, loss of appetite, pain and spasticity. And a growing body of literature suggests that cannabis may hold the key to unlocking new treatments for HIV/AIDS, Multiple Sclerosis, cancer, and many other conditions. Year after year, the research has been twisted or ignored to suit a political ideology.

The federal government is lying when it states that the therapeutic use of cannabis has no accepted medical value in treatment in the United States.”

via This is your chance to tell the White House… | Gather.

Related posts

• Two San Antonio women die from Fentanyl patches (2)
• President Obama’s DEA raids at least two Los Angeles area dispensaries (10)
• Oregon set to reschedule marijuana from I to II, III, IV, or V by 2010 (6)

A Polk County judge ruled Thursday that the Iowa Pharmacy Board must examine whether marijuana has an accepted medical use, a decision some said could unfreeze debate on the drug’s use for medical purposes in Iowa.

The ruling, handed down by Polk County District Judge Joel D. Novak, would not legalize marijuana for medical purposes in the state. Instead, it forces the pharmacy board to consider whether it is properly classified as a Schedule I controlled substance under Iowa law.

Four petitioners asked the board to review the drug’s classification last summer. The board ruled in October that the petitioners had to prove that the drug lacked a high potential for abuse before it would be reclassified. The American Civil Liberties Union of Iowa appealed the decision.

via Board must study whether marijuana is accepted medical use | DesMoinesRegister.com | The Des Moines Register.

“Must examine whether marijuana has an accepted medical use…”  Only one?  Do the opinions of thirteen states count?  This is like trying to determine whether the guy with one leg is actually disabled (happened to a friend of mine; he just took off his prosthetic and set it on the counter at the DMV and asked, “what do you think?”)

Related posts

• Iowa Stasher RevRayGreen Tells Lawmakers to Support Medical Marijuana (3)
• Iowa nurses aide fired for providing medical marijuana and sexual favors to muscular dystrophy patient (5)
• Iowa Board of Pharmacy to hold medical marijuana classification hearings (5)

First, the good news, something the migraine/cluster headache medical marijuana patient for whom I am a caregiver could’ve told you without any scientific studies:

Cluster Attacks Responsive to Recreational Cannabis and Dronabinol

Pharmacological preparations of cannabinoid compounds have a variety of therapeutic uses in medicine, including different pain syndromes, but have not been previously reported as beneficial for cluster headache. We present a patient with cluster headache who was refractory to multiple acute and preventive medications but successfully aborted his attacks with recreational marijuana use; subsequent use of dronabinol provided equally effective pain relief.

In other words, some people can kill their severe headaches by smoking pot or taking Marinol pills.

But once you dig past the abstract and into the full text of the paper, you step through Alice’s looking glass into the world where 100% potent synthetic THC is a Schedule III prescribable drug and 5%-20% potent natural THC + other medical cannabinoids is a Schedule I illegal drug.

Read the rest of this entry by clicking here

Related posts

• Los Angeles Times: Reefer-tax madness (2)
• Oregon set to reschedule marijuana from I to II, III, IV, or V by 2010 (6)
• Two San Antonio women die from Fentanyl patches (2)

[Welcome to the Stash the prolific MrSpof, who will be dishing out some of that Fresh Stash right here on the Main Page.  This is an experiment that may end at any time, but I really want to expand the Stash, on a model somewhat like "DailyKos", where there will be additional front page contributors.  I will maintain editorial control.  If you want on the Main Page, show your stuff on the Fresh Stash.  Don't solicit me for Main Page; if I spot you from thirty-to-fifty or so words, quality links, and persistance, I'll contact you. -- "R"R]

It is almost beyond dispute that the federal laws are unjustified by science or common sense. Under the 1970 Controlled Substances Act, cannabis is a Schedule 1 drug, meaning it has no medical use and cannot be prescribed by a physician. The many medical uses of marijuana are well documented, and it is not nearly as addictive or intoxicating as less-restricted Schedule 2 drugs such as cocaine and methamphetamine. Moreover, the active ingredient in marijuana, THC, can be sold in pill form as a Schedule 3 drug. So what makes the plant so dangerous?

via Editorial: Reefer-tax madness – Los Angeles Times

It is quite refreshing to see a major media source like the LA Times bringing up one of the things that frustrates me the most about the War on US Citizens. Why is marijuana a Class 1 drug with ‘no medicinal value’ if the The United States of America, as represented by the Department of Health and Human Services holds US Patent 6630507 titled “Cannabinoids as antioxidants and neuroprotectants”?

The patent claims that “Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases. The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in the treatment of neurodegenerative diseases, such as Alzheimer’s disease, Parkinson’s disease and HIV dementia.”

via Digital Journal US Government Holds Patent For Medical Marijuana, Shows Hypocrisy

Related posts

• Oregon set to reschedule marijuana from I to II, III, IV, or V by 2010 (6)
• Cluster headaches responsive to smoking cannabis… so use Marinol? (2)
• Two San Antonio women die from Fentanyl patches (2)